Skip to main content

Published locations for AUGMENT: Lenalidomide/Rituximab vs Placebo/Rituximab in Relapsed or Refractory Indolent Lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. AUGMENT: Lenalidomide/Rituximab vs Placebo/Rituximab in Relapsed or Refractory Indolent Lymphoma

User login

  • Reset your password
  • /content/augment-lenalidomide/rituximab-vs-placebo/rituximab-relapsed-or-refractory-indolent-lymphoma
  • /jcomjournal/article/208643/hematology/augment-lenalidomide/rituximab-vs-placebo/rituximab-relapsed